21 Stocks Moving In Friday's Pre-Market Session

Gainers

• Oasmia Pharmaceutical AB OASM shares rose 64.2% to $2.0201 in pre-market trading after Oasmia and Arwidsro solved outstanding balances. Arwidsro increaseD its investment in Oasmia.
• DBV Technologies S.A. DBVT rose 22.2% to $11.54 in pre-market trading after gaining 8.38% on Wednesday.
• Maxar Technologies Inc.. MAXR rose 9% to $9.89 in pre-market trading.
• Veru Inc. VERU rose 7.6% to $2.40 in pre-market trading.
• Karyopharm Therapeutics Inc. KPTI rose 6.4% to $9.47 in pre-market trading on continued strength after the company on Wednesday announced FDA approval of XPOVIO for treatment of patients with relapsed, refractory multiple myeloma.
• Fortuna Silver Mines Inc. FSM rose 5.5% to $3.05 in pre-market trading.
• Moderna, Inc. MRNA shares rose 4.5% to $16.00 in pre-market trading.
• B&G Foods, Inc. BGS rose 4.1% to $21.65 in pre-market trading.
• Alteryx, Inc. AYX shares rose 4.1% to $120.00 in pre-market trading.
• NIO Inc. NIO rose 3.8% to $3.25 in pre-market trading after gaining 10.99% on Wednesday.
• Diamondback Energy, Inc. FANG rose 3.6% to $108.99 in pre-market trading.
• Grifols, S.A. GRFS rose 2.8% to $22.00 in pre-market trading after the company reported the FDA approval of Xembify, its new 20% subcutaneous immunoglobulin for treating primary immunodeficiencies.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Melinta Therapeutics, Inc. MLNT fell 12.8% to $6.88 in pre-market trading after rising 17.94% on Wednesday.
• Mmtec, Inc. MTC shares fell 7.7% to $16.63 in pre-market trading .
• Reebonz Holding Limited RBZ fell 7.6% to $3.64 in pre-market trading after dropping 5.74% on Wednesday.
• Fate Therapeutics, Inc. FATE fell 6.4% to $20.50 in pre-market trading after gaining 6.46% on Wednesday.
• AllianceBernstein Holding L.P. AB fell 4.9% to $28.83 in pre-market trading.
• Celyad SA CYAD fell 4.7% to $12.92 in pre-market trading after the company issued update on autologous & allogeneic NKG2D-based CAR-T therapies in solid tumors.
• Rio Tinto Group RIO fell 4.6% to $60.37 in pre-market trading.
• BHP Group BBL fell 4.6% to $49.30 in pre-market trading.
• TTM Technologies, Inc. TTMI fell 3.9% to $9.50 in pre-market trading.